NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/19/2025
Back to search
Official data from USPTO
ONCOBODIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOBODIES
ST13
US500000079368859Class
1, 5, 42, 44
Filing
79368859
Registration
7376665
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
09/20/2025
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
02/02/2023
Registration date
05/07/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/07/2024
Last transaction
09/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
NL
Examiner
VAGHANI, MAYUR
Law office
N60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
LinXis B.V.
Representatives
Roberta S. Bren MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals; carrier excipients for use in the manufacture of pharmaceutical preparations
Class 5
Drug delivery agents in the form of powderstablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biochemical medicines for the treatment of cancer; chemical preparations for pharmaceutical purposesfor the treatment of cancer; diagnostic agents for pharmaceutical purposes; pharmaceutical substances and preparations for the treatment of cancer
Class 42
Pharmaceutical research services; scientific research in the nature of conducting clinical trials for pharmaceuticals for others; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; research services in the field of proteinsantibodiesmicroorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology
Class 44
In vitro analysis for medical and pharmaceutical useanalysis for medical diagnostic or treatment purposes; in vitro testing for medical and pharmaceutical usetesting for medical diagnostic or treatment purposes; consultancy and information services provided via the Internet relating to pharmaceutical productsnamely pharmaceutical consultation
Publications
History of USPTO decisions and trademark events.
29 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/14/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/23/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/04/2024
FIMP
FINAL DISPOSITION PROCESSED
11/04/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/20/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
GPNX
NOTIFICATION PROCESSED BY IB
02/27/2024
PUBO
PUBLISHED FOR OPPOSITION
02/20/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/07/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/27/2023
RFNP
REFUSAL PROCESSED BY IB
11/28/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/07/2023
RFRR
REFUSAL PROCESSED BY MPU
11/07/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/07/2023
CNRT
NON-FINAL ACTION WRITTEN
11/06/2023
DOCK
ASSIGNED TO EXAMINER
11/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
05/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/05/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/04/2023
Continuous trademark protection
Get notified about every new filing that threatens ONCOBODIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.